American Health Packaging is recalling 11 lots of Ranitidine tablets.
The medication, used for treatment of ulcers, may be contaminated with N-nitrosodimethylamine (NDMA), a probable cancer-causer.
There are no reports of injury or adverse events to date.
The following lots of the histamine-2 blocker, which decreases the amount of acid created by the stomach, are being recalled:
AHP Lot No.
|AHP Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters|
Carton NDC#: 60687-322-01
(Individual Dose NDC: 60687-322-11)
The recalled product was distributed to wholesalers nationwide for use in hospitals.
What to do
Pharmacies that have received the recalled product should contact the company at (877) 475-5864 from 9:00 am - 5:00 pm (EST) Monday thru Friday to receive a return packet.
Consumers who have the recalled products should stop using them, and may contact Inmar Pharmaceuticals Services at (800) 967-5952 (option 1) from 9:00 am - 5:00 pm (EST) Monday through Friday for more information.